Skip to main content
. 2019 Dec 31;18:1533033819893667. doi: 10.1177/1533033819893667

Table 6.

The Influence of Serum CD4+CD25+ T Cells, NK Cells, and T Cells Subgroup Before and After Therapy in PFS (Apatinib Group).

Immune Cells Case mPFS (months) 95% CI P
CD4+CD25+ cells
 Increased 26 5.8 3.635-7.965 .012
 Decrease 16 2.9 1.804-3.999
NK cells
 Increased 19 3.3 1.233-5.367 .697
 Decrease 23 4.6 3.438-5.762
T cells
 Increased 25 4.4 2.588-6.212 .880
 Decrease 17 4.5 1.258-7.742

Abbreviations: CI, confidence interval; NK, natural killer; PFS, progression-free survival.